Frazier Life Sciences
North America, California, United States, Menlo Park
Description
Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages.
Investor Profile
Frazier Life Sciences has made 42 investments, with 16 in the past 12 months and 31% as lead.
Stage Focus
- Post Ipo Equity (48%)
- Series B (17%)
- Series A (14%)
- Series C (10%)
- Series E (2%)
- Series Unknown (2%)
- Seed (2%)
- Undisclosed (2%)
- Series D (2%)
Country Focus
- United States (74%)
- Canada (7%)
- United Kingdom (7%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Sweden (5%)
- Switzerland (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Biopharma
- Life Science
- Oncology
- Product Research
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
